Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 16;30(8):1782.
doi: 10.3390/molecules30081782.

Molecular-Based Nanoplatform Leads to the Formation of a Self-Indicating Responsive Drug Delivery System

Affiliations

Molecular-Based Nanoplatform Leads to the Formation of a Self-Indicating Responsive Drug Delivery System

Lingbo Zhang et al. Molecules. .

Abstract

We report the design and biological evaluation of a nanoplatform featuring controllable aggregation-induced emission (AIE) behavior. The free rotation of benzene rings (4-(1,2,2-triphenylvinyl) benzaldehyde) largely suppresses fluorescence in the pure organic phase. However, water-induced molecular aggregation enhances the fluorescence signal. The delivery system follows the membrane-cytoplasm-nucleus route and it leads to apoptosis in two cancer cells (U937 cells and Hela cells). The AIE moiety accumulates in the cytoplasm, emitting a bright-blue signal, but the anticancer drug doxorubicin selectively targets the nucleus with unique red emission. The current noninvasive method with DOX-triggered apoptosis holds promise for tumor diagnosis and real-time imaging.

Keywords: cellular imaging; fluorescence; nanoplatform; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structure of TPE-CHO and the preparation of TD NPs and the subsequent utilization of the TD NPs for cell therapy. Different color of cells indicates the co-localization of TPE-CHO with lysosomes (blue to green), the internal red fluorescence from DOX corresponds to nuclear staining.
Figure 2
Figure 2
Emission changes of TPE-CHO (25 μM) in DMSO/water mixtures with different concentrations of water.
Figure 3
Figure 3
Fluorescence spectra of TD NPs (25 μM) with different excitation wavelengths (Ex = 370 nm and 490 nm) at pH 7.4 and 5.0.
Figure 4
Figure 4
TEM images of TPE-CHO NPs (A) and TD NPs (B) (pH = 7.4).
Figure 5
Figure 5
Cell viability of TPE-CHO NPs, DOX, and TD NPs towards to U937 cells.
Figure 6
Figure 6
Representative distribution of U937 (A,C) and Hela cells (B,D) obtained by Annexin V-APC/PI staining experiments. Cells of (A,B) were treated with 25 μM TPE-CHO NPs, and (C,D) were treated with 25 μM TD NPs. Color dots from blue to red refer to cell density increase.
Figure 7
Figure 7
Confocal microscopy images of U937 cells cultured with TD NPs (25 μM), free DOX (5 μM), and TD NPs (25 μM) and co-stained with Lysotracker Green after a 4 h incubation. Different color of cells indicates the co-localization of TPE-CHO with lysosomes (blue to green), the internal red fluorescence from DOX corresponds to nuclear staining.
Figure 8
Figure 8
Confocal microscopy images of Hela cells cultured with TD NPs (25 μM), free DOX (5 μM), and TD NPs (25 μM) and co-stained with Lysotracker Green after a 4 h incubation. Different color of cells indicates the co-localization of TPE-CHO with lysosomes (blue to green), the internal red fluorescence from DOX corresponds to nuclear staining.

Similar articles

References

    1. Zhou Z., Zhang C.C., Zheng Y., Wang Q. Aggregation Induced Emission Mediated Controlled Release by Using a Built-In Functionalized Nanocluster with Theranostic Features. J. Med. Chem. 2016;59:410–418. doi: 10.1021/acs.jmedchem.5b01622. - DOI - PubMed
    1. Arias J.L. Drug Targeting Strategies in Cancer Treatment: An Overview. Mini-Rev. Med. Chem. 2011;11:1–17. doi: 10.2174/138955711793564024. - DOI - PubMed
    1. Chandana M., Manasi D., Jagat R.K., Sanjeeb K.S. Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy. Curr. Drug Deliv. 2011;8:45–58. - PubMed
    1. Mura S., Nicolas J., Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 2013;12:991–1003. doi: 10.1038/nmat3776. - DOI - PubMed
    1. Nguyen K.T., Zhao Y. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics. Acc. Chem. Res. 2015;48:3016–3025. doi: 10.1021/acs.accounts.5b00316. - DOI - PubMed

LinkOut - more resources